Morton Grove Pharmaceuticals
GPTKB entity
Properties (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:affiliation |
Pharmaceutical_Research_and_Manufacturers_of_America_(PhRMA)
|
| gptkbp:awards |
Various industry recognitions
|
| gptkbp:brand |
Recognized brand in pharmaceuticals
|
| gptkbp:businessModel |
B2B_and_B2C
|
| gptkbp:CEO |
David_A._Heller
|
| gptkbp:clinicalTrials |
Conducts clinical trials
|
| gptkbp:communityInvolvement |
Local health initiatives
|
| gptkbp:communityOutreach |
Health education programs
|
| gptkbp:communityPartnerships |
Strategic supply partnerships
|
| gptkbp:corporateSocialResponsibility |
Active CSR initiatives
|
| gptkbp:customerBase |
Hospitals and clinics
|
| gptkbp:customerFeedback |
Values customer feedback
|
| gptkbp:customerSupport |
Dedicated customer support team
|
| gptkbp:distribution |
Nationwide
|
| gptkbp:employees |
Approximately 200
Comprehensive employee benefits High employee engagement levels |
| gptkbp:exportMarkets |
International markets
|
| gptkbp:financials |
Privately held
Invests in community health programs |
| gptkbp:founded |
1975
|
| gptkbp:hasResearchInterest |
Conducts market research
|
| gptkbp:headquarters |
gptkb:Morton_Grove,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Morton Grove Pharmaceuticals
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:innovation |
Focus on new drug formulations
|
| gptkbp:investmentFocus |
Invests in technology upgrades
|
| gptkbp:isFacilitatedBy |
Stringent quality assurance processes
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
gptkb:North_America
Regular product launches Strong_market_presence_in_the_U.S. |
| gptkbp:marketingStrategy |
Plans for business continuity.
|
| gptkbp:marketSegment |
Targeted marketing campaigns
|
| gptkbp:mission |
To provide high-quality pharmaceuticals
|
| gptkbp:network |
Engages in industry networking events
|
| gptkbp:parentCompany |
gptkb:Heller_&_Heller,_Inc.
|
| gptkbp:partnerships |
Various healthcare organizations
Collaborations with research institutions |
| gptkbp:patentCitation |
Holds multiple patents
|
| gptkbp:productionCompany |
cGMP compliant
|
| gptkbp:productLine |
Injectables
|
| gptkbp:productQuality |
High product quality
|
| gptkbp:products |
Ongoing product development
Prioritizes product safety Generic_medications |
| gptkbp:regulatoryCompliance |
Meets all regulatory requirements
FDA_approved |
| gptkbp:researchAndDevelopment |
Yes
|
| gptkbp:researchFocus |
Therapeutic areas
|
| gptkbp:safety |
High safety standards
|
| gptkbp:services |
Contract manufacturing
|
| gptkbp:specialization |
Injectable pharmaceuticals
|
| gptkbp:supplyChain |
Robust supply chain management
|
| gptkbp:sustainabilityPractices |
Environmentally responsible manufacturing
|
| gptkbp:technology |
Integrates advanced technology in operations
|
| gptkbp:training |
Continuous professional development
|
| gptkbp:vision |
To be a leader in the pharmaceutical industry
|
| gptkbp:website |
www.mortongrovepharma.com
|
| gptkbp:youth_development |
Consistent financial growth
|